Skip to main content
Top
Published in: Heart and Vessels 9/2023

19-04-2023 | Systemic Lupus Erythematosus | Original Article

Mean pulmonary artery pressure estimated by echocardiogram rapidly exceeds 20 mmHg from the normal range in patients with connective tissue disease

Authors: Yoshiyuki Orihara, Masanori Asakura, Kyung-Duk Min, Yuki Matsumoto, Isamu Sunayama, Koichi Nishimura, Akiyo Eguchi, Yoshitaka Okuhara, Masaharu Ishihara

Published in: Heart and Vessels | Issue 9/2023

Login to get access

Abstract

Earlier intervention for pulmonary hypertension (PH) has been reported to improve the prognosis of patients with connective tissue disease (CTD). However, it is not fully elucidated how rapidly PH develops in patients showing normal mean pulmonary arterial pressure (mPAP) at the index investigation. We evaluated 191 CTD patients with normal mPAP retrospectively. The mPAP was estimated by the formerly defined method employing echocardiography (mPAPecho). We investigated predictive factors that predict increasing mPAPecho at follow-up transthoracic echocardiography (TTE) using uni- and multi variable analysis. The mean age was 61.5 years old, and 160 patients were female. The percentage of patients in whom mPAPecho exceeded 20 mmHg at follow-up TTE was 38%. Multivariable analysis revealed that acceleration time/ejection time (AcT/ET) measured at the right ventricular outflow tract at initial TTE was independently associated with the consequent increase of mPAPecho at the follow-up TTE. When using 0.43 of best cutoff value in AcT/ET calculated by receiver operating characteristic analysis, the change in mPAPecho in patients with low AcT/ET was significantly higher than in those with high AcT/ET (3.05 mmHg in patients with AcT/ET < 0.43 and 1.00 mmHg in patients with AcT/ET ≥ 0.43, p < 0.001). Thirty-eight percent of CTD patients who show the normal estimated mPAP by TTE develop gradual elevation of mPAP to the level to consider early intervention within 2 years. AcT/ET at initial TTE can predict increasing mPAP at follow-up TTE.
Literature
1.
go back to reference Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, Ito H, Kuwana M, Matsubara H, Momomura SI, Nishimura M, Ogino H, Satoh T, Shimokawa H, Yamauchi-Takihara K, Tatsumi K, Ishibashi-Ueda H, Yamada N, Yoshida S, Abe K, Ogawa A, Ogo T, Kasai T, Kataoka M, Kawakami T, Kogaki S, Nakamura M, Nakayama T, Nishizaki M, Sugimura K, Tanabe N, Tsujino I, Yao A, Akasaka T, Ando M, Kimura T, Kuriyama T, Nakanishi N, Nakanishi T, Tsutsui H; Japanese Circulation Society and the Japanese Pulmonary Circulation and Pulmonary Hypertension Society Joint Working Group (2019) Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017). Circ J 83(4):842–945 Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, Ito H, Kuwana M, Matsubara H, Momomura SI, Nishimura M, Ogino H, Satoh T, Shimokawa H, Yamauchi-Takihara K, Tatsumi K, Ishibashi-Ueda H, Yamada N, Yoshida S, Abe K, Ogawa A, Ogo T, Kasai T, Kataoka M, Kawakami T, Kogaki S, Nakamura M, Nakayama T, Nishizaki M, Sugimura K, Tanabe N, Tsujino I, Yao A, Akasaka T, Ando M, Kimura T, Kuriyama T, Nakanishi N, Nakanishi T, Tsutsui H; Japanese Circulation Society and the Japanese Pulmonary Circulation and Pulmonary Hypertension Society Joint Working Group (2019) Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017). Circ J 83(4):842–945
2.
go back to reference Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, Miller DP, Nicolls MR, Zamanian RT (2010) Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest 138(6):1383–1394CrossRefPubMedPubMedCentral Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, Miller DP, Nicolls MR, Zamanian RT (2010) Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest 138(6):1383–1394CrossRefPubMedPubMedCentral
3.
go back to reference Okamura M, Konishi M, Saigusa Y, Ando S, Nakayama M, Komura N, Sugano T, Tamura K, Nakamura T (2022) Impact of grip strength and gait speed on exercise tolerance in patients with pulmonary hypertension without left heart disease. Heart Vessels 37:1928–1936CrossRefPubMed Okamura M, Konishi M, Saigusa Y, Ando S, Nakayama M, Komura N, Sugano T, Tamura K, Nakamura T (2022) Impact of grip strength and gait speed on exercise tolerance in patients with pulmonary hypertension without left heart disease. Heart Vessels 37:1928–1936CrossRefPubMed
4.
go back to reference Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173(9):1023–1030CrossRefPubMed Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173(9):1023–1030CrossRefPubMed
5.
go back to reference Tamura Y, Kumamaru H, Satoh T, Miyata H, Ogawa A, Tanabe N, Hatano M, Yao A, Abe K, Tsujino I, Fukuda K, Kimura H, Kuwana M, Matsubara H, Tatsumi K; Japan PH Registry (JAPHR) Network (2017) Effectiveness and outcome of pulmonary arterial hypertension-specific therapy in Japanese patients with pulmonary arterial hypertension. Circ J 82(1):275–282 Tamura Y, Kumamaru H, Satoh T, Miyata H, Ogawa A, Tanabe N, Hatano M, Yao A, Abe K, Tsujino I, Fukuda K, Kimura H, Kuwana M, Matsubara H, Tatsumi K; Japan PH Registry (JAPHR) Network (2017) Effectiveness and outcome of pulmonary arterial hypertension-specific therapy in Japanese patients with pulmonary arterial hypertension. Circ J 82(1):275–282
6.
go back to reference Humbert M, Sitbon O, Yaïci A, Montani D, O’Callaghan DS, Jaïs X, Parent F, Savale L, Natali D, Günther S, Chaouat A, Chabot F, Cordier JF, Habib G, Gressin V, Jing ZC, Souza R, Simonneau G, Network FPAH (2010) Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 36(3):549–555CrossRefPubMed Humbert M, Sitbon O, Yaïci A, Montani D, O’Callaghan DS, Jaïs X, Parent F, Savale L, Natali D, Günther S, Chaouat A, Chabot F, Cordier JF, Habib G, Gressin V, Jing ZC, Souza R, Simonneau G, Network FPAH (2010) Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 36(3):549–555CrossRefPubMed
7.
go back to reference Rhee RL, Gabler NB, Sangani S, Praestgaard A, Merkel PA, Kawut SM (2015) Comparison of treatment response in idiopathic and connective tissue disease-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 192(9):1111–1117CrossRefPubMedPubMedCentral Rhee RL, Gabler NB, Sangani S, Praestgaard A, Merkel PA, Kawut SM (2015) Comparison of treatment response in idiopathic and connective tissue disease-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 192(9):1111–1117CrossRefPubMedPubMedCentral
8.
go back to reference Chung L, Farber HW, Benza R, Miller DP, Parsons L, Hassoun PM, McGoon M, Nicolls MR, Zamanian RT (2014) Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chest 146(6):1494–1504CrossRefPubMedPubMedCentral Chung L, Farber HW, Benza R, Miller DP, Parsons L, Hassoun PM, McGoon M, Nicolls MR, Zamanian RT (2014) Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chest 146(6):1494–1504CrossRefPubMedPubMedCentral
9.
go back to reference Li C, Li K, Wang F, Rao L (2022) Amount of dissipative energy loss when assessing left ventricular dysfunction in female patients with systemic lupus erythematosus. Heart Vessels 37(7):1175–1183CrossRefPubMed Li C, Li K, Wang F, Rao L (2022) Amount of dissipative energy loss when assessing left ventricular dysfunction in female patients with systemic lupus erythematosus. Heart Vessels 37(7):1175–1183CrossRefPubMed
10.
go back to reference Oktay AA, Mandras SA, Shah S, Kancharla K, Shams OF, Pascual MI, Morin DP (2020) First in human: the effects of biventricular pacing on cardiac output in severe pulmonary arterial hypertension. Heart Vessels 35(6):852–858CrossRefPubMed Oktay AA, Mandras SA, Shah S, Kancharla K, Shams OF, Pascual MI, Morin DP (2020) First in human: the effects of biventricular pacing on cardiac output in severe pulmonary arterial hypertension. Heart Vessels 35(6):852–858CrossRefPubMed
11.
go back to reference Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, Gressin V, Guillevin L, Clerson P, Simonneau G, Hachulla E (2011) Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 63(11):3522–3530CrossRefPubMed Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, Gressin V, Guillevin L, Clerson P, Simonneau G, Hachulla E (2011) Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 63(11):3522–3530CrossRefPubMed
12.
go back to reference Anavekar NS, Gerson D, Skali H, Kwong RY, Yucel EK, Solomon SD (2007) Two-dimensional assessment of right ventricular function: an echocardiographic-MRI correlative study. Echocardiography 24(5):452–456CrossRefPubMed Anavekar NS, Gerson D, Skali H, Kwong RY, Yucel EK, Solomon SD (2007) Two-dimensional assessment of right ventricular function: an echocardiographic-MRI correlative study. Echocardiography 24(5):452–456CrossRefPubMed
13.
go back to reference Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S (2022) ESC/ERS Scientific Document Group. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43(38):3618–3731 Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S (2022) ESC/ERS Scientific Document Group. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43(38):3618–3731
14.
go back to reference Chemla D, Castelain V, Humbert M, Hébert JL, Simonneau G, Lecarpentier Y, Hervé P (2004) New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 126(4):1313–1317CrossRefPubMed Chemla D, Castelain V, Humbert M, Hébert JL, Simonneau G, Lecarpentier Y, Hervé P (2004) New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 126(4):1313–1317CrossRefPubMed
15.
go back to reference Parasuraman S, Walker S, Loudon LB, Gollop DN, Wilson MA, Lowery C, Frenneaux PM (2016) Assessment of pulmonary artery pressure by echocardiography—a comprehensive review. Int J Cardiol Heart Vasc 12:45–51PubMedPubMedCentral Parasuraman S, Walker S, Loudon LB, Gollop DN, Wilson MA, Lowery C, Frenneaux PM (2016) Assessment of pulmonary artery pressure by echocardiography—a comprehensive review. Int J Cardiol Heart Vasc 12:45–51PubMedPubMedCentral
16.
go back to reference Shen H, Zhang J, Wang C, Jain PP, Xiong M, Shi X, Lei Y, Chen S, Yin Q, Thistlethwaite PA, Wang J, Gong K, Yuan ZY, Yuan JX, Shyy JY (2020) MDM2-mediated ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension. Circulation 142:1190–1204CrossRefPubMedPubMedCentral Shen H, Zhang J, Wang C, Jain PP, Xiong M, Shi X, Lei Y, Chen S, Yin Q, Thistlethwaite PA, Wang J, Gong K, Yuan ZY, Yuan JX, Shyy JY (2020) MDM2-mediated ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension. Circulation 142:1190–1204CrossRefPubMedPubMedCentral
17.
go back to reference Pratali L, Allemann Y, Rimoldi SF, Faita F, Hutter D, Rexhaj E, Brenner R, Bailey DM, Sartori C, Salmon CS, Villena M, Scherrer U, Picano E, Sicari R (2013) RV contractility and exercise-induced pulmonary hypertension in chronic mountain sickness: a stress echocardiographic and tissue Doppler imaging study. JACC Cardiovasc Imaging 6:1287–1297CrossRefPubMed Pratali L, Allemann Y, Rimoldi SF, Faita F, Hutter D, Rexhaj E, Brenner R, Bailey DM, Sartori C, Salmon CS, Villena M, Scherrer U, Picano E, Sicari R (2013) RV contractility and exercise-induced pulmonary hypertension in chronic mountain sickness: a stress echocardiographic and tissue Doppler imaging study. JACC Cardiovasc Imaging 6:1287–1297CrossRefPubMed
18.
go back to reference Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ (2003) A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 41(6):1021–1027CrossRefPubMed Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ (2003) A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 41(6):1021–1027CrossRefPubMed
19.
go back to reference Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transp 48(3):452–458CrossRef Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transp 48(3):452–458CrossRef
21.
go back to reference Shirai Y, Yasuoka H, Okano Y, Takeuchi T, Satoh T, Kuwana M (2012) Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort. Rheumatology (Oxford) 51(10):1846–1854CrossRefPubMed Shirai Y, Yasuoka H, Okano Y, Takeuchi T, Satoh T, Kuwana M (2012) Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort. Rheumatology (Oxford) 51(10):1846–1854CrossRefPubMed
22.
go back to reference Hao YJ, Jiang X, Zhou W, Wang Y, Gao L, Wang Y, Li GT, Hong T, Huo Y, Jing ZC, Zhang ZL (2014) Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients. Eur Respir J 44(4):963–972CrossRefPubMed Hao YJ, Jiang X, Zhou W, Wang Y, Gao L, Wang Y, Li GT, Hong T, Huo Y, Jing ZC, Zhang ZL (2014) Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients. Eur Respir J 44(4):963–972CrossRefPubMed
23.
go back to reference Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, Joynt KE, Kass DJ, Stephens T, Stanislawski MA, Swenson ER, Goldstein RH, Leopold JA, Zamanian RT, Elwing JM, Plomondon ME, Grunwald GK, Barón AE, Rumsfeld JS, Choudhary G (2016) Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the veterans affairs clinical assessment, reporting, and tracking program. Circulation 133(13):1240–1248CrossRefPubMedPubMedCentral Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, Joynt KE, Kass DJ, Stephens T, Stanislawski MA, Swenson ER, Goldstein RH, Leopold JA, Zamanian RT, Elwing JM, Plomondon ME, Grunwald GK, Barón AE, Rumsfeld JS, Choudhary G (2016) Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the veterans affairs clinical assessment, reporting, and tracking program. Circulation 133(13):1240–1248CrossRefPubMedPubMedCentral
24.
go back to reference Douschan P, Kovacs G, Avian A, Foris V, Gruber F, Olschewski A, Olschewski H (2018) Mild elevation of pulmonary arterial pressure as a predictor of mortality. Am J Respir Crit Care Med 197(4):509–516CrossRefPubMed Douschan P, Kovacs G, Avian A, Foris V, Gruber F, Olschewski A, Olschewski H (2018) Mild elevation of pulmonary arterial pressure as a predictor of mortality. Am J Respir Crit Care Med 197(4):509–516CrossRefPubMed
25.
go back to reference Assad TR, Maron BA, Robbins IM, Xu M, Huang S, Harrell FE, Farber-Eger EH, Wells QS, Choudhary G, Hemnes AR, Brittain EL (2017) Prognostic effect and longitudinal hemodynamic assessment of borderline pulmonary hypertension. JAMA Cardiol 2(12):1361–1368CrossRefPubMedPubMedCentral Assad TR, Maron BA, Robbins IM, Xu M, Huang S, Harrell FE, Farber-Eger EH, Wells QS, Choudhary G, Hemnes AR, Brittain EL (2017) Prognostic effect and longitudinal hemodynamic assessment of borderline pulmonary hypertension. JAMA Cardiol 2(12):1361–1368CrossRefPubMedPubMedCentral
27.
28.
go back to reference Dorfmüller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22(2):358–363CrossRefPubMed Dorfmüller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22(2):358–363CrossRefPubMed
29.
go back to reference Klein-Weigel P, Opitz C, Riemekasten G (2011) Systemic sclerosis—a systematic overview: part 1—disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance. Vasa 40(1):6–19CrossRefPubMed Klein-Weigel P, Opitz C, Riemekasten G (2011) Systemic sclerosis—a systematic overview: part 1—disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance. Vasa 40(1):6–19CrossRefPubMed
30.
go back to reference Cutolo M, Soldano S, Smith V (2019) Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Rev Clin Immunol 15(7):753–764CrossRefPubMed Cutolo M, Soldano S, Smith V (2019) Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Rev Clin Immunol 15(7):753–764CrossRefPubMed
31.
go back to reference Sasaki N, Kamataki A, Sawai T (2011) A histopathological study of pulmonary hypertension in connective tissue disease. Allergol Int 60(4):411–417CrossRefPubMed Sasaki N, Kamataki A, Sawai T (2011) A histopathological study of pulmonary hypertension in connective tissue disease. Allergol Int 60(4):411–417CrossRefPubMed
32.
go back to reference Zaky A, Zafar I, Masjoan-Juncos JX, Husain M, Mariappan N, Morgan CJ, Hamid T, Frölich MA, Ahmad S, Ahmad A (2021) Echocardiographic, biochemical, and electrocardiographic correlates associated with progressive pulmonary arterial hypertension. Front Cardiovasc Med 8:705666CrossRefPubMedPubMedCentral Zaky A, Zafar I, Masjoan-Juncos JX, Husain M, Mariappan N, Morgan CJ, Hamid T, Frölich MA, Ahmad S, Ahmad A (2021) Echocardiographic, biochemical, and electrocardiographic correlates associated with progressive pulmonary arterial hypertension. Front Cardiovasc Med 8:705666CrossRefPubMedPubMedCentral
33.
go back to reference Miyanaga S, Kubota K, Iwatani N, Higo K, Miyata M, Horizoe Y, Ojima S, Kawasoe S, Kubozono T, Ohishi M (2019) Predictors of exercise-induced pulmonary hypertension in patients with connective tissue disease. Heart Vessels 34(9):1509–1518CrossRefPubMed Miyanaga S, Kubota K, Iwatani N, Higo K, Miyata M, Horizoe Y, Ojima S, Kawasoe S, Kubozono T, Ohishi M (2019) Predictors of exercise-induced pulmonary hypertension in patients with connective tissue disease. Heart Vessels 34(9):1509–1518CrossRefPubMed
34.
go back to reference Serra W, Chetta A, Santilli D, Mozzani F, Dall’Aglio PP, Olivieri D, Cattabiani MA, Ardissino D, Gherli T (2010) Echocardiography may help detect pulmonary vasculopathy in the early stages of pulmonary artery hypertension associated with systemic sclerosis. Cardiovasc Ultrasound 8:25CrossRefPubMedPubMedCentral Serra W, Chetta A, Santilli D, Mozzani F, Dall’Aglio PP, Olivieri D, Cattabiani MA, Ardissino D, Gherli T (2010) Echocardiography may help detect pulmonary vasculopathy in the early stages of pulmonary artery hypertension associated with systemic sclerosis. Cardiovasc Ultrasound 8:25CrossRefPubMedPubMedCentral
35.
go back to reference Wang YC, Huang CH, Tu YK (2018) Pulmonary hypertension and pulmonary artery acceleration time: a systematic review and meta-analysis. J Am Soc Echocardiogr 31(2):201-210.e3CrossRefPubMed Wang YC, Huang CH, Tu YK (2018) Pulmonary hypertension and pulmonary artery acceleration time: a systematic review and meta-analysis. J Am Soc Echocardiogr 31(2):201-210.e3CrossRefPubMed
36.
go back to reference D’Alto M, Di Maio M, Romeo E, Argiento P, Blasi E, Di Vilio A, Rea G, D’Andrea A, Golino P, Naeije R (2022) Echocardiographic probability of pulmonary hypertension: a validation study. Eur Respir J 60(2):2102548CrossRefPubMed D’Alto M, Di Maio M, Romeo E, Argiento P, Blasi E, Di Vilio A, Rea G, D’Andrea A, Golino P, Naeije R (2022) Echocardiographic probability of pulmonary hypertension: a validation study. Eur Respir J 60(2):2102548CrossRefPubMed
37.
go back to reference Kitabatake A, Inoue M, Asao M, Masuyama T, Tanouchi J, Morita T, Mishima M, Uematsu M, Shimazu T, Hori M, Abe H (1983) Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 68:302–309CrossRefPubMed Kitabatake A, Inoue M, Asao M, Masuyama T, Tanouchi J, Morita T, Mishima M, Uematsu M, Shimazu T, Hori M, Abe H (1983) Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 68:302–309CrossRefPubMed
38.
go back to reference Habash S, Laser TK, Moosmann J, Reif R, Adler W, Glöckler M, Kececioglu D, Dittrich S (2019) Normal values of the pulmonary artery acceleration time (PAAT) and the right ventricular ejection time (RVET) in children and adolescents and the impact of the PAAT/RVET-index in the assessment of pulmonary hypertension. Int J Cardiovasc Imaging 35:295–306CrossRefPubMed Habash S, Laser TK, Moosmann J, Reif R, Adler W, Glöckler M, Kececioglu D, Dittrich S (2019) Normal values of the pulmonary artery acceleration time (PAAT) and the right ventricular ejection time (RVET) in children and adolescents and the impact of the PAAT/RVET-index in the assessment of pulmonary hypertension. Int J Cardiovasc Imaging 35:295–306CrossRefPubMed
39.
go back to reference Shivkumar K, Ravi K, Henry WJ, Eichenhorn M, Stein DP (1994) Right ventricular dilatation, right ventricular wall thickening, and Doppler evidence of pulmonary hypertension in patients with a pure restrictive ventilatory impairment. Chest 106:1649–1653CrossRefPubMed Shivkumar K, Ravi K, Henry WJ, Eichenhorn M, Stein DP (1994) Right ventricular dilatation, right ventricular wall thickening, and Doppler evidence of pulmonary hypertension in patients with a pure restrictive ventilatory impairment. Chest 106:1649–1653CrossRefPubMed
Metadata
Title
Mean pulmonary artery pressure estimated by echocardiogram rapidly exceeds 20 mmHg from the normal range in patients with connective tissue disease
Authors
Yoshiyuki Orihara
Masanori Asakura
Kyung-Duk Min
Yuki Matsumoto
Isamu Sunayama
Koichi Nishimura
Akiyo Eguchi
Yoshitaka Okuhara
Masaharu Ishihara
Publication date
19-04-2023

Other articles of this Issue 9/2023

Heart and Vessels 9/2023 Go to the issue